Investor Relations

Webcast ImageWebcast
C. R. Bard, Inc. at the Morgan Stanley Global Healthcare Conference (Replay)
09/13/16 at 1:30 p.m. ET
C. R. Bard, Inc. at the Morgan Stanley Global Healthcare Conference
Tuesday, September 13, 2016 1:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Download DocumentationQ2 2016 Earnings Presentation
Download DocumentationAnalyst Meeting Presentation
BCR (Common Stock)
ExchangeNYSE (US Dollar)
Price$229.91
Change (%) Stock is Down 1.44 (0.62%)
Volume504,149
Data as of 09/23/16 4:02 p.m. ET
Minimum 20 minute delay
Refresh quote
Featured Reports
Download Documentation2016 Proxy Statement
Download Documentation2015 Annual Report
Related Links
Corporate Governance
Contact the Bard Board of Directors
Recent NewsMore >>
DateTitle 
09/22/16LUTONIX® Global Real-World Registry 24-Month Outcomes Presented at VIVA 2016
MURRAY HILL, N.J.--(BUSINESS WIRE)--Sep. 22, 2016-- C. R. Bard, Inc. (NYSE:BCR) announced the presentation of the final 24-month results from the LUTONIX® Global Real-World Registry at the Vascular Intervention Advances (VIVA) 2016 Meeting. These results are the first reported final 24-month outcomes for “real-word” registry data for Drug Coated Balloon PTA Catheters (DCBs). The registry includes a subgroup of patients with long femoropopliteal lesions (... 
Printer Friendly Version
09/19/16FDA Approves 6-Month Primary End Point for the Lutonix® Below-the-Knee Drug Coated Balloon
MURRAY HILL, N.J.--(BUSINESS WIRE)--Sep. 19, 2016-- C. R. Bard, Inc. (NYSE: BCR) today announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption (IDE) supplemental application to modify the primary endpoint to a 6-month time point for the Lutonix® 014 Drug Coated Balloon PTA Catheter (DCB). The Lutonix® 014 device is currently the only DCB in an IDE clinical trial in the U.S. for treatment of arteries below ... 
Printer Friendly Version
09/06/16Bard to Present at Morgan Stanley Global Healthcare Conference
MURRAY HILL, N.J.--(BUSINESS WIRE)--Sep. 6, 2016-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will present at the Morgan Stanley Global Healthcare Conference in New York City on September 13, 2016. Christopher S. Holland, senior vice president and chief financial officer, will discuss the Company in a presentation scheduled to begin at 1:30 PM Eastern Daylight Time. A live webcast of Bard's presentation will be accessible to all i... 
Printer Friendly Version
07/26/16Bard Announces Second Quarter Results
MURRAY HILL, N.J.--(BUSINESS WIRE)--Jul. 26, 2016-- C. R. Bard, Inc. (NYSE:BCR) today reported 2016 second quarter financial results. Second quarter 2016 net sales were $931.5 million, an increase of 8 percent over the prior-year period on an as-reported basis. Excluding the impact of foreign exchange, second quarter 2016 net sales increased 9 percent over the prior-year period. For the second quarter 2016, net sales in the U.S. were $633.1 milli... 
Printer Friendly Version
Selected SEC Filings
Filing DateForm
07/27/1610-Q Download SEC Filing to Adobe PDF Download XBRL Content
04/28/1610-Q Download SEC Filing to Adobe PDF Download XBRL Content
02/12/1610-K Download SEC Filing to Adobe PDF Download XBRL Content
10/23/1510-Q Download SEC Filing to Adobe PDF Download XBRL Content
07/24/1510-Q Download SEC Filing to Adobe PDF Download XBRL Content
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever C. R. Bard, Inc. posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.